Stockscreener 앱 받기
1.71
5.00%
-0.09
시간 외 거래:
1.70
-0.01
-0.58%
Caribou Biosciences Inc 주식(CRBU)의 최신 뉴스
Caribou Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - Investing News Network
Caribou Biosciences earnings beat by $0.04, revenue topped estimates - Investing.com Canada
Caribou Biosciences, Inc. (CRBU) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Caribou Biosciences (NASDAQ:CRBU) Posts Earnings Results, Beats Estimates By $0.05 EPS - MarketBeat
Caribou Biosciences announces Q4 and FY2025 financial results, Caribou Biosciences outlines - Traders Union
Insights into Caribou Biosciences Q4 Earnings - Benzinga
CRBU: Strong clinical progress and improved financials position the pipeline for pivotal trials - TradingView
BRIEF-Caribou Biosciences Q4 Licensing And Collaboration Revenue USD 3.941 Million - TradingView
CRBU Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Caribou Biosciences (CRBU) to Release Earnings on Monday - MarketBeat
Insider Sell: Timothy Kelly Sells Shares of Caribou Biosciences Inc (CRBU) - GuruFocus
Caribou Biosciences Inc expected to post a loss of 31 cents a shareEarnings Preview - TradingView
Caribou Biosciences (CRBU) CTO sells 6,228 shares in open-market trade - Stock Titan
7 Top Gene-Editing Stocks to Buy - US News Money
Caribou Biosciences (NASDAQ: CRBU) notice to sell 6,938 vested shares - Stock Titan
Caribou Biosciences (NASDAQ: CRBU) files Rule 144 to sell 6,938 shares - Stock Titan
Timothy Kelly sells 3,147 CRBU shares; proposed sale of 6,228 restricted shares (CRBU) - Stock Titan
Decliners Report: Is Roivant Sciences Ltd stock undervalued right nowJuly 2025 Update & Daily Growth Stock Tips - baoquankhu1.vn
Caribou Biosciences (NASDAQ:CRBU) Insider Ruhi Ahmad Khan Sells 6,938 Shares - MarketBeat
Caribou Biosciences CLO sold $13,598 in CRBU stock - Investing.com Australia
Caribou Biosciences CLO sold $13,598 in CRBU stock By Investing.com - Investing.com Canada
Caribou Biosciences CTO Kelly sells $6.1k in shares By Investing.com - Investing.com Canada
Khan, Caribou Biosciences CBO, sells $13598 in stock - Investing.com Australia
Khan, Caribou Biosciences CBO, sells $13598 in stock By Investing.com - Investing.com Canada
Caribou Biosciences (CRBU) CBO awarded stock options, sells shares for tax - Stock Titan
Caribou (CRBU) CMO gets 247,500 options, small tax-related sale - Stock Titan
Growth Value: Is Caribou Biosciences Inc benefiting from interest rate changesMarket Risk Report & Intraday High Probability Alerts - baoquankhu1.vn
Earnings Risk: Is Magyar Bancorp Inc stock a falling knife or bargain buyJuly 2025 Weekly Recap & Long-Term Safe Investment Ideas - baoquankhu1.vn
Caribou Biosciences Details Pivotal-Ready Vispa-cel Plan, Flags Need for More Capital at Citi Summit - MarketBeat
Should you avoid Caribou Biosciences Inc. stock right now2025 Earnings Impact & Weekly Watchlist for Consistent Profits - mfd.ru
Volume Report: Is NCIQ stock forming a cup and handleSwing Trade & Weekly High Potential Alerts - baoquankhu1.vn
Short Squeeze: How does Caribou Biosciences Inc compare to its peersInflation Watch & Technical Pattern Recognition Alerts - baoquankhu1.vn
Director at Caribou Biosciences (CRBU) awarded option for 45,000 shares - Stock Titan
Caribou Biosciences (CRBU) CEO receives large new equity grants - Stock Titan
Is Caribou Biosciences Inc. stock a top performer YTDWeekly Trade Report & Low Drawdown Momentum Trade Ideas - mfd.ru
Caribou Biosciences (CRBU)’s CB-011 may reach $734 million in peak 2040 sales, according to Clear Street - MSN
Caribou Biosciences (CRBU)’s CB-011 May Reach $734 Million in Peak 2040 Sales, According to Clear Street - Yahoo Finance
Caribou Biosciences (CRBU)'s CB-011 May Reach $734 Million in Peak 2040 Sales, According to Clear Street - Finviz
Is Caribou Biosciences Inc. stock risky to hold nowJuly 2025 Outlook & AI Forecasted Stock Moves - mfd.ru
Can Caribou Biosciences Inc. stock hit record highs again2025 Key Highlights & AI Powered Market Trend Analysis - mfd.ru
Watchmaker Genomics Licenses CRISPR-Cas9 Intellectual Property from Caribou Biosciences to Increase Throughput and Reduce Sequencing Cost Per Sample - marketscreener.com
Watchmaker Genomics Licenses CRISPR-Cas9 Intellectual Property from Caribou Biosciences to Increase Throughput and Reduce Sequencing Cost per Sample - BioSpace
Will Caribou Biosciences Inc. stock benefit from infrastructure spendingQuarterly Profit Report & Real-Time Volume Spike Alerts - mfd.ru
Caribou Biosciences to Participate in Upcoming Investor Conferences - The Manila Times
Will Caribou Biosciences Inc. stock benefit from upcoming earnings reportsMarket Sentiment Summary & Weekly Return Optimization Plans - mfd.ru
Merger Talk: Is Caribou Biosciences Inc stock showing strong momentum2025 Trading Volume Trends & Verified Stock Trade Ideas - baoquankhu1.vn
CRISPR-focused Caribou set for fireside chats at 2 investor events - Stock Titan
Caribou Biosciences, Inc. (CRBU) Presents at 2026 Tandem Meetings of ASTCT and CIBMTRSlideshow - Seeking Alpha
What is Brookline Cap M's Forecast for CRBU FY2030 Earnings? - MarketBeat
Research Analysts Offer Predictions for CRBU FY2030 Earnings - MarketBeat
Bond Watch: How does Caribou Biosciences Inc compare to its peersLayoff News & AI Enhanced Trading Signals - baoquankhu1.vn
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN), Caribou Biosciences (CRBU) and Boston Scientific (BSX) - The Globe and Mail
Caribou Biosciences (NASDAQ:CRBU) Shares Up 3.8%What's Next? - MarketBeat
Caribou Biosciences Announces Late-Breaking Presentations at the 2026 Tandem Meetings of ASTCT® and CIBMTR - Investing News Network
3.69%
0.68%
자본화:
|
볼륨(24시간):